Intended for healthcare professionals


In brief

BMJ 1999; 319 doi: (Published 24 July 1999) Cite this as: BMJ 1999;319:210

UK agrees new drug pricing scheme: The United Kingdom last week agreed new terms for the Pharmaceutical Price Regulation Scheme—a voluntary system setting out the profit that manufacturers can earn on the sale of brand name products to the NHS. The terms of the scheme agreed a price reduction of 4.5% on branded medicines and a ban on price …

View Full Text

Log in

Log in through your institution


* For online subscription